HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-137 Cr | ₹-174 Cr | ₹-292 Cr | ₹-284 Cr | ₹-156 Cr |
What is the latest Cash Flow from Investing Activities ratio of HIKAL ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-137 Cr |
| Mar2024 | ₹-174 Cr |
| Mar2023 | ₹-292 Cr |
| Mar2022 | ₹-284 Cr |
| Mar2021 | ₹-156 Cr |
How is Cash Flow from Investing Activities of HIKAL Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-137 Cr | Negative | |
| Mar2024 | ₹-174 Cr | Negative | |
| Mar2023 | ₹-292 Cr | Negative | |
| Mar2022 | ₹-284 Cr | Negative | |
| Mar2021 | ₹-156 Cr | - | |
Compare Cash Flow from Investing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,369.2 Cr | 7.8% | 4.5% | -52.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 7.8% |
4.5% |
-52.9% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses